JRCT ID: jRCTs032180377
Registered date:19/03/2019
iASSIST study
Basic Information
Recruitment status | Complete |
---|---|
Health condition(s) or Problem(s) studied | Osteoarthritis |
Date of first enrollment | 18/08/2017 |
Target sample size | 100 |
Countries of recruitment | |
Study type | Interventional |
Intervention(s) | Investigational group: Persona TKA with iASSIST Knee as the Investigational group Control group: Persona TKA with conventional instrumentation and without iASSIST Knee as the Control group |
Outcome(s)
Primary Outcome | The alignment accuracy of the knee femoral and tibial components at 6 months for the investigational group compared to the control group. |
---|---|
Secondary Outcome | Health Status assessed with the EQ-5D form Surgery time from skin incision to closure Any adverse events (including device related, non-device related, procedure related, non-procedure related) Number of instrument trays used |
Key inclusion & exclusion criteria
Age minimum | >= 20age old |
---|---|
Age maximum | Not applicable |
Gender | Both |
Include criteria | Knee (either unilateral or bilateral) osteoarthritis (varus deformity only) Male or female At least 20 years of age Patients willing to return for follow-up evaluations. |
Exclude criteria | Absolute contraindications include: Knee degenerative diseases other than knee osteoarthritis (such as necrosis/rheumatoid arthritis) Too severe OA deformation (FTA: > 190 degrees/< 175 degrees) Active infection (or within 6 weeks after infection) Sepsis Osteomyelitis Any type of implant is inserted in the affected side of lower extremity Hip and/or foot disease on the affected side Additional contraindications include: Uncooperative patient or patient with neurologic disorders who are incapable of following directions Diagnosed osteoporosis or osteomalacia Metabolic disorders which may impair bone formation Distant foci of infections which may spread to the implant site Rapid joint destruction, marked bone loss or bone resorption apparent on roentgenogram Vascular insufficiency, muscular atrophy or neuromuscular disease. |
Related Information
Primary Sponsor | Ohdera Toshihiro |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | Zimmer Biomet G.K. |
Secondary ID(s) | NCT03227692/ UMIN000027545 |
Contact
Public contact | |
Name | Toshihiro Ohdera |
Address | 10-50 Yanagouchi 2-chome, Minami-ku, Fukuoka, Fukuoka 815-0063, Japan Fukuoka Japan 815-0063 |
Telephone | +81-92-512-1581 |
ohdera@fukuokaseikei.com | |
Affiliation | Fukuoka Orthopaedic Hospital |
Scientific contact | |
Name | Toshihiro Ohdera |
Address | 10-50 Yanagouchi 2-chome, Minami-ku, Fukuoka, Fukuoka 815-0063, Japan Fukuoka Japan 815-0063 |
Telephone | +81-92-512-1581 |
ohdera@fukuokaseikei.com | |
Affiliation | Fukuoka Orthopaedic Hospital |